Lais T. Da Silva
Br. 05403-903
Sao Paulo, SP 05403903, Brazil
Sao Paulo, SP 05403903, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Vaccine Immunogenicity to SARS-CoV-2 in Renal Transplant Patients Under Three Different Immunosuppressive Regimens: Evaluation of Antibody Titers.
Journal: Transplantation proceedings
Published: December 30, 2025
Induction of HIV-Specific T Cell Responses Using αDC1 Pulsed With Conserved HIV-1 Peptides.
Journal: Journal of immunology research
Published: October 13, 2025
Salivary, serological, and cellular immune response to the CoronaVac vaccine in health care workers with or without previous COVID-19.
Journal: Scientific reports
Published: January 18, 2022
Patient with agammaglobulinemia produces anti-SARS-CoV-2 reactive T-cells after CoronaVac vaccine.
Journal: Clinics (Sao Paulo, Brazil)
Published: November 26, 2021
What Happens to the Immune System after Vaccination or Recovery from COVID-19?
Journal: Life (Basel, Switzerland)
Published: September 20, 2021
Immunogenicity of personalized dendritic-cell therapy in HIV-1 infected individuals under suppressive antiretroviral treatment: interim analysis from a phase II clinical trial.
Journal: AIDS research and therapy
Published: September 07, 2021
Antagonistic role of IL-1ß and NLRP3/IL-18 genetics in chronic HIV-1 infection.
Journal: Clinical immunology (Orlando, Fla.)
Published: August 28, 2019
Phenotypic and functional profile of IFN-α-differentiated dendritic cells (IFN-DCs) from HIV-infected individuals.
Journal: Human vaccines & immunotherapeutics
Published: November 15, 2018
Using Dendritic Cell-Based Immunotherapy to Treat HIV: How Can This Strategy be Improved?
Journal: Frontiers in immunology
Published: July 27, 2018
Host genetics contributes to the effectiveness of dendritic cell-based HIV immunotherapy.
Journal: Human vaccines & immunotherapeutics
Published: April 12, 2018
Showing 1-11 of 11
Last Updated: 09/26/2026